The long-term objectives of this project are to identify the cis-acting regulatory elements and transcription factors that are responsible for kidney-specific gene expression. The proposed studies will examine the renal absorptive Na-K-Cl cotransporter (Nkcc2/Slc12a1) as a model kidney- specific gene. In the kidney, NKCC2 mediates active reabsorption of NaCl in the thick ascending limb of the loop of Henle and represents the site of action of the clinically important loop diuretics furosemide and bumetanide. Importantly, expression of Nkcc2 transcripts is only observed in the kidney. Recent studies demonstrate that the Nkcc2 gene is under transcriptional control and that the Nkcc2 promoter exhibits cell-lineage- specific activity. The proposed studies will test the hypothesis that kidney-specific transcription of Nkcc2 is mediated by the interaction between kidney-enriched transcription factors and regulatory elements of the Nkcc2 gene. To identify regulatory elements that are responsible for kidney-specific promoter activity, fragments of the proximal 5' flanking region of the Nkcc2 gene will be ligated to a promoterless reporter gene and transiently expressed in cultured kidney cells. Evidence for cell- type-specific promoter activity will be obtained by transfection into cells of differing lineages. It will be important to verify that regulatory elements identified in vitro also confer kidney-specificity upon expression of a lacZ reporter gene in transgenic mice. Specific enhancer and negative regulatory elements within the 5' flanking region will be identified by deletion analysis and phylogenetic sequence conservation. Regulatory elements located elsewhere in the gene will be identified on the basis of DNase I hypersensitivity. Whether candidate regions contain kidney-specific regulatory elements will be determined by evaluating their effects on transcription from a heterologous promoter both in vitro and in vivo. Electrophoretic mobility-shift assays will be performed to determine whether cis-acting elements bind to kidney-enriched nuclear proteins. Specific sites of DNA-protein interaction will be defined using in vitro DNA footprinting, and the effects of mutations of the elements on protein-binding and transcriptional activity will be assessed. Transcription factors that bind to relevant regulatory elements will be identified by Southwestern blotting or UV crosslinking, and cDNAs encoding these proteins will be cloned by screening expression libraries with recognition site probes. Identification of the cis-acting regulatory elements that are required for transcription of Nkcc2 will provide general insights into mechanisms of kidney-specific gene expression: will be important for future studies of dysregulated expression of Nkcc2 in states of abnormal renal salt handling, such as Bartter's syndrome and essential hypertension; and will provide reagents that may be useful for future in vivo gene therapy of the kidney. Characterization of the transcription factors involved in expression of Nkcc2 may also be clinically important since mutations affecting such proteins may cause developmental, neoplastic, or cystic disorders of the kidney.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042921-08
Application #
2900229
Study Section
General Medicine B Study Section (GMB)
Project Start
1991-04-15
Project End
1999-08-31
Budget Start
1999-04-01
Budget End
1999-08-31
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Granberg, Candace F; Harrison, Steven M; Dajusta, Daniel et al. (2012) Genetic basis of prune belly syndrome: screening for HNF1? gene. J Urol 187:272-8
Choi, Yun-Hee; Suzuki, Akira; Hajarnis, Sachin et al. (2011) Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases. Proc Natl Acad Sci U S A 108:10679-84
Verdeguer, Francisco; Le Corre, Stephanie; Fischer, Evelyne et al. (2010) A mitotic transcriptional switch in polycystic kidney disease. Nat Med 16:106-10
Patel, Vishal; Chowdhury, Renuka; Igarashi, Peter (2009) Advances in the pathogenesis and treatment of polycystic kidney disease. Curr Opin Nephrol Hypertens 18:99-106
Gong, Yimei; Ma, Zhendong; Patel, Vishal et al. (2009) HNF-1beta regulates transcription of the PKD modifier gene Kif12. J Am Soc Nephrol 20:41-7
Shibazaki, Sekiya; Yu, Zhiheng; Nishio, Saori et al. (2008) Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum Mol Genet 17:1505-16
Williams, Scott S; Cobo-Stark, Patricia; James, Leighton R et al. (2008) Kidney cysts, pancreatic cysts, and biliary disease in a mouse model of autosomal recessive polycystic kidney disease. Pediatr Nephrol 23:733-41
Zhang, Yanling; Wada, Jun; Yasuhara, Akihiro et al. (2007) The role for HNF-1beta-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PLoS One 2:e414
Ma, Zhendong; Gong, Yimei; Patel, Vishal et al. (2007) Mutations of HNF-1beta inhibit epithelial morphogenesis through dysregulation of SOCS-3. Proc Natl Acad Sci U S A 104:20386-91
Hiesberger, Thomas; Shao, Xinli; Gourley, Eric et al. (2005) Role of the hepatocyte nuclear factor-1beta (HNF-1beta) C-terminal domain in Pkhd1 (ARPKD) gene transcription and renal cystogenesis. J Biol Chem 280:10578-86

Showing the most recent 10 out of 24 publications